Rapkin Andrea J, Morgan Melinda, Sogliano Cristiana, Biggio Giovanni, Concas Alessandra
Department of Obstetrics and Gynecology, David Geffen School of Medicine, University of California-Los Angeles, Los Angeles, California 90095-1740, USA.
Fertil Steril. 2006 May;85(5):1371-8. doi: 10.1016/j.fertnstert.2005.10.031. Epub 2006 Apr 3.
To evaluate the effects of a low-dose combined oral contraceptive pill (OCP) on peripheral neuroactive steroid concentrations, precursors for neuroactive steroid synthesis, and mood in healthy women desiring contraception. These neuroactive steroids are gamma-aminobutyric acid receptor agonists and are important in the modulation of affect and adaptation to stress.
Prospective observational study.
Human ambulatory patient study.
PATIENT(S): Healthy OCP-naive women without current or history of affective disorder.
INTERVENTION(S): A 0.020-mg ethinyl E2-0.1-mg levonorgestrel containing OCP for 3 months.
MAIN OUTCOME MEASURE(S): Serum neuroactive steroids allopregnanolone, allotetrahydrodeoxycorticosterone, and DHEA; neuroactive steroid precursors P and pregnenolone; E2; and mood and anxiety as assessed by the Premenstrual Syndrome Daily Ratings Form, Beck Depression Inventory, Spielberger State-Trait Anxiety Inventory, and Profile of Mood States.
RESULT(S): The combined OCP resulted in a decrease in neuroactive steroids and neuroactive steroid precursors as well as in E2. However, this decline was not associated with adverse mood changes on any of the well-validated assessment tools.
CONCLUSION(S): Healthy women without underlying mood or anxiety disorder who were given a low-dose OCP did not experience adverse psychological symptoms despite a significant reduction in neuroactive steroids.
评估低剂量复方口服避孕药(OCP)对希望避孕的健康女性外周神经活性甾体浓度、神经活性甾体合成前体及情绪的影响。这些神经活性甾体是γ-氨基丁酸受体激动剂,在情感调节和应激适应中起重要作用。
前瞻性观察性研究。
人类门诊患者研究。
无情感障碍病史及当前发作的未服用过OCP的健康女性。
服用含0.020mg炔雌醇和0.1mg左炔诺孕酮的OCP,为期3个月。
血清神经活性甾体别孕烷醇酮、别四氢脱氧皮质酮和脱氢表雄酮;神经活性甾体前体P和孕烯醇酮;雌二醇;以及通过经前综合征每日评分表、贝克抑郁量表、斯皮尔伯格状态-特质焦虑量表和情绪状态剖面图评估的情绪和焦虑。
复方OCP导致神经活性甾体、神经活性甾体前体以及雌二醇水平降低。然而,在任何经过充分验证的评估工具上,这种下降均未伴随不良情绪变化。
在未患潜在情绪或焦虑障碍的健康女性中,给予低剂量OCP后,尽管神经活性甾体显著减少,但未出现不良心理症状。